P222 Systemic inflammation markers as predictors of axillary clearance: a multicenter analysis on 1274 nodal positive breast cancer patients undergoing primary systemic treatment.

MLA

Gasparri, M. L., et al. “P222 Systemic Inflammation Markers as Predictors of Axillary Clearance: A Multicenter Analysis on 1274 Nodal Positive Breast Cancer Patients Undergoing Primary Systemic Treatment.” Breast, vol. 68, Apr. 2023, p. S104. EBSCOhost, https://doi.org/10.1016/S0960-9776(23)00340-5.

APA

Gasparri, M. L., Albasini, S., Truffi, M., Tagliaferri, B., Sottotetti, F., Armatura, G., Listorti, C., Rovera, F. A., Combi, F., Tognali, D., Della Valle, A., Mele, S., Ghilli, M., Mancini, S., & Corsi, F. (2023). P222 Systemic inflammation markers as predictors of axillary clearance: a multicenter analysis on 1274 nodal positive breast cancer patients undergoing primary systemic treatment. Breast, 68, S104. https://doi.org/10.1016/S0960-9776(23)00340-5

Chicago

Gasparri, M.L., S. Albasini, M. Truffi, B. Tagliaferri, F. Sottotetti, G. Armatura, C. Listorti, et al. 2023. “P222 Systemic Inflammation Markers as Predictors of Axillary Clearance: A Multicenter Analysis on 1274 Nodal Positive Breast Cancer Patients Undergoing Primary Systemic Treatment.” Breast 68 (April): S104. doi:10.1016/S0960-9776(23)00340-5.